365 related articles for article (PubMed ID: 32289501)
21. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.
Lindesmith LC; Beltramello M; Donaldson EF; Corti D; Swanstrom J; Debbink K; Lanzavecchia A; Baric RS
PLoS Pathog; 2012; 8(5):e1002705. PubMed ID: 22615565
[TBL] [Abstract][Full Text] [Related]
22. Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera.
Malm M; Tamminen K; Vesikari T; Blazevic V
Viral Immunol; 2018 Dec; 31(10):649-657. PubMed ID: 30431404
[TBL] [Abstract][Full Text] [Related]
23. High serum levels of norovirus genotype-specific blocking antibodies correlate with protection from infection in children.
Malm M; Uusi-Kerttula H; Vesikari T; Blazevic V
J Infect Dis; 2014 Dec; 210(11):1755-62. PubMed ID: 24970849
[TBL] [Abstract][Full Text] [Related]
24. Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity.
Debbink K; Donaldson EF; Lindesmith LC; Baric RS
J Virol; 2012 Jan; 86(2):1214-26. PubMed ID: 22090110
[TBL] [Abstract][Full Text] [Related]
25. Norovirus Gastroenteritis in a Birth Cohort in Southern India.
Menon VK; George S; Sarkar R; Giri S; Samuel P; Vivek R; Saravanabavan A; Liakath FB; Ramani S; Iturriza-Gomara M; Gray JJ; Brown DW; Estes MK; Kang G
PLoS One; 2016; 11(6):e0157007. PubMed ID: 27284939
[TBL] [Abstract][Full Text] [Related]
26. Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades.
Sharma S; Carlsson B; Czakó R; Vene S; Haglund M; Ludvigsson J; Larson G; Hammarström L; Sosnovtsev SV; Atmar RL; Green KY; Estes MK; Svensson L
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468886
[TBL] [Abstract][Full Text] [Related]
27. Heterotypic humoral and cellular immune responses following Norwalk virus infection.
Lindesmith LC; Donaldson E; Leon J; Moe CL; Frelinger JA; Johnston RE; Weber DJ; Baric RS
J Virol; 2010 Feb; 84(4):1800-15. PubMed ID: 20007270
[TBL] [Abstract][Full Text] [Related]
28. Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection.
Tan M; Jin M; Xie H; Duan Z; Jiang X; Fang Z
J Med Virol; 2008 Jul; 80(7):1296-301. PubMed ID: 18461617
[TBL] [Abstract][Full Text] [Related]
29. Relationship between GII.3 norovirus infections and blood group antigens in young children in Tunisia.
Ayouni S; Estienney M; Sdiri-Loulizi K; Ambert-Balay K; de Rougemont A; Aho S; Hammami S; Aouni M; Guédiche MN; Pothier P; Belliot G
Clin Microbiol Infect; 2015 Sep; 21(9):874.e1-8. PubMed ID: 26003283
[TBL] [Abstract][Full Text] [Related]
30. A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies.
Atmar RL; Ettayebi K; Ramani S; Neill FH; Lindesmith L; Baric RS; Brinkman A; Braun R; Sherwood J; Estes MK
J Infect Dis; 2024 May; 229(5):1402-1407. PubMed ID: 37781879
[TBL] [Abstract][Full Text] [Related]
31. Cellular and humoral immunity following Snow Mountain virus challenge.
Lindesmith L; Moe C; Lependu J; Frelinger JA; Treanor J; Baric RS
J Virol; 2005 Mar; 79(5):2900-9. PubMed ID: 15709009
[TBL] [Abstract][Full Text] [Related]
32. Norovirus and histo-blood group antigens.
Shirato H
Jpn J Infect Dis; 2011; 64(2):95-103. PubMed ID: 21519121
[TBL] [Abstract][Full Text] [Related]
33. Antibody prevalence and titer to norovirus (genogroup II) correlate with secretor (FUT2) but not with ABO phenotype or Lewis (FUT3) genotype.
Larsson MM; Rydell GE; Grahn A; Rodriguez-Diaz J; Akerlind B; Hutson AM; Estes MK; Larson G; Svensson L
J Infect Dis; 2006 Nov; 194(10):1422-7. PubMed ID: 17054072
[TBL] [Abstract][Full Text] [Related]
34. A homozygous nonsense mutation (428G-->A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections.
Thorven M; Grahn A; Hedlund KO; Johansson H; Wahlfrid C; Larson G; Svensson L
J Virol; 2005 Dec; 79(24):15351-5. PubMed ID: 16306606
[TBL] [Abstract][Full Text] [Related]
35. Genetic Susceptibility to Human Norovirus Infection: An Update.
Nordgren J; Svensson L
Viruses; 2019 Mar; 11(3):. PubMed ID: 30845670
[TBL] [Abstract][Full Text] [Related]
36. Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations.
Donaldson EF; Lindesmith LC; Lobue AD; Baric RS
Immunol Rev; 2008 Oct; 225():190-211. PubMed ID: 18837783
[TBL] [Abstract][Full Text] [Related]
37. Norovirus infection and HBGA host genetic susceptibility in a birth community-cohort, Rio de Janeiro, Brazil.
Cantelli CP; Fumian TM; Malta FC; da Cunha DC; Brasil P; Nordgren J; Svensson L; Miagostovich MP; de Moraes MTB; Leite JPG
Infect Genet Evol; 2020 Aug; 82():104280. PubMed ID: 32165242
[TBL] [Abstract][Full Text] [Related]
38. [Genetic susceptibility to norovirus infection].
Ruvoën N; Le Pendu J
Pathol Biol (Paris); 2013 Jan; 61(1):28-35. PubMed ID: 23399413
[TBL] [Abstract][Full Text] [Related]
39. Norovirus Infection in Young Nicaraguan Children Induces Durable and Genotype-Specific Antibody Immunity.
Brewer-Jensen PD; Reyes Y; Becker-Dreps S; González F; Mallory ML; Gutiérrez L; Zepeda O; Centeno E; Vielot N; Diez-Valcarce M; Vinjé J; Baric R; Lindesmith LC; Bucardo F
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146859
[TBL] [Abstract][Full Text] [Related]
40. The endemic GII.4 norovirus-like-particle induced-antibody lacks of cross-reactivity against the epidemic GII.17 strain.
Du J; Gu Q; Liu Y; Li Q; Guo T; Liu Y
J Med Virol; 2021 Jun; 93(6):3974-3979. PubMed ID: 32869863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
